SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029938
Filing Date
2020-06-19
Accepted
2020-06-19 16:09:59
Documents
14
Period of Report
2020-06-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ortx-8k_20200617.htm   iXBRL 8-K 84390
2 EX-3.1 ortx-ex31_7.htm EX-3.1 1054853
3 GRAPHIC gpj4bfwcxoqi000001.jpg GRAPHIC 21645
  Complete submission text file 0001564590-20-029938.txt   1408762

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ortx-20200617.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20200617_lab.xml EX-101.LAB 19400
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20200617_pre.xml EX-101.PRE 11609
12 EXTRACTED XBRL INSTANCE DOCUMENT ortx-8k_20200617_htm.xml XML 3603
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 20975727
SIC: 2836 Biological Products, (No Diagnostic Substances)